Toggle navigation
Home
Search
Services
Blog
Contact
About
HIV Vaccine Design and Development Teams /HVDDT/-26630029
Alphavax Human Vaccines. Inc.
Search grants from Alphavax Human Vaccines. Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Publications
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Genomic Instability and Cancer Genetics
Using single cell RNA-seq to study regulatory noise and robustness
Disorders of Sex Development: Platform for Basic and Translational Research
Skill acquisition in older adults
Mammalian Oxidative DNA Damage Repair
Recently added grants:
ENdotypes in Children with Severe Acute Respiratory Distress SyNdrome: ImpAct on REsponse to Treatment (ENSNARE)
Rectifying splicing mutations in blood disorders by gene editing
Developing a Data-Driven Management System Using Machine Learning and Mixed-Methods Research to Predict Job Turnover Among MentalHealth Professionals
Viral and Host Determinants of Cognitive Status in Vertically Transmitted HIV
Evaluating the HITSystem to Improve PMTCT Retention and Maternal Viral Suppression in Kenya
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research and Development Contracts (N01)
Project #
N01AI030029-001
Application #
6994681
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2004
Total Cost
Indirect Cost
Institution
Name
Alphavax Human Vaccines. Inc.
Department
Type
DUNS #
City
State
Country
Zip Code
Publications
Wecker, M; Gilbert, P; Russell, N et al.
(2012)
Phase I safety and immunogenicity evaluations of an alphavirus replicon HIV-1 subtype C gag vaccine in healthy HIV-1-uninfected adults.
Clin Vaccine Immunol 19:1651-60
Comments
Be the first to comment on this grant
